IoM’s Drug Safety Cmte. Will Meet In June; Panel Includes Ex-FDAer Ellenberg
The Institute of Medicine's Drug Safety Committee will convene June 8 to begin discussing its review of FDA's post-marketing oversight system
The Institute of Medicine's Drug Safety Committee will convene June 8 to begin discussing its review of FDA's post-marketing oversight system